Organon introduces global ESG strategy

Organon introduces global ESG strategy

Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health

  • By IPP Bureau | June 04, 2022

Organon, a global women’s healthcare company, announced the publication of its inaugural Environmental, Social, and Governance (ESG) Report for 2021. The ESG report introduces the company’s ESG platform, known as Her Promise, and details how the company is working to help women and girls achieve the full potential of their promise through better health. The publication of the ESG Report and launch of Her Promise coincides with Organon’s one year anniversary and reflects the company’s vision to create a better and healthier every day for every woman around the world.

As the only global women’s healthcare company of its kind, Organon is well positioned to help address several current and growing women’s health challenges.

“In just one year, Organon has made considerable progress in addressing gender-related disparities in health by listening to women and investing in areas where high unmet needs exist. Since our launch, we have focused on treatment gaps that need to be addressed, like unintended pregnancy, fertility, post-partum hemorrhage, pre-term labor, endometriosis and bacterial vaginosis, and will continue to strive to deliver innovation, improve access and expand choice for treatments areas that uniquely or disproportionately affect women,” says Kevin Ali, Organon’s Chief Executive Officer.

“The goals stated in our first ESG Report create a roadmap for the future of how we will continue to propel forward and partner to transform the current women’s health environment.”

“We intend to uphold Organon’s HER Promise for every woman in India. As a new and energetic company, powered with its legacy in women’s health, Organon in India will work with the local stakeholders to bring quality medicines. Our portfolio in fertility and contraception will empower Indian women with greater choice and better control over her health” says Anjan Sen, Organon India’s Commercial Lead.

Upcoming E-conference

Other Related stories